Marina Stolina

Marina Stolina

UNVERIFIED PROFILE

Are you Marina Stolina?   Register this Author

Register author
Marina Stolina

Marina Stolina

Publications by authors named "Marina Stolina"

Are you Marina Stolina?   Register this Author

57Publications

1338Reads

32Profile Views

Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Bone 2019 Aug 28:115047. Epub 2019 Aug 28.

Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis, St. Louis, MO 63110, USA; Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2019.115047DOI Listing
August 2019

Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism.

Calcif Tissue Int 2017 12 16;101(6):641-653. Epub 2017 Oct 16.

Departments of Cardiometabolic Disorders and Comparative Biology and Safety Sciences, Amgen Inc., One Amgen Center Drive, MS: 36-2-A, Thousand Oaks, CA, 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-017-0319-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660836PMC
December 2017

Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.

J Bone Miner Res 2016 09 9;31(9):1774-82. Epub 2016 May 9.

Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.2842DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010446PMC
September 2016

Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice.

J Bone Miner Res 2014 ;29(5):1158-69

Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece; Biomedical Sciences Research Center "Alexander Fleming", Vari, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.2112DOI Listing
December 2014

Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

J Bone Miner Res 2014 Dec;29(12):2601-9

Center for Metabolic Bone Disease and Molecular Research, Shriners Hospital for Children, St. Louis, MO, USA; Division of Bone and Mineral Diseases, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbmr.2289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391634PMC
December 2014

Progressive increases in bone mass and bone strength in an ovariectomized rat model of osteoporosis after 26 weeks of treatment with a sclerostin antibody.

Endocrinology 2014 Dec 26;155(12):4785-97. Epub 2014 Sep 26.

Departments of Metabolic Disorders (X.L., Q.-T.N., K.S.W., F.J.A., D.D., M.G., C.-Y.H., M.S., P.J.K., W.S.S., M.S.O., H.Z.K.) and Biostatistics (M.J.E.), Amgen Inc, Thousand Oaks, California 91320.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2013-1905DOI Listing
December 2014

Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading.

J Bone Miner Res 2013 Apr;28(4):865-74

Harvard-Massachusetts Institute of Technology (MIT) Division of Health Sciences and Technology (HST), Bioastronautics Program, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://bouxseinlab.org/Spatz%20JBMR%202013.pdf
Web Search
http://doi.wiley.com/10.1002/jbmr.1807
Publisher Site
http://dx.doi.org/10.1002/jbmr.1807DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076162PMC
April 2013

Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody.

Calcif Tissue Int 2012 Jul 27;91(1):50-8. Epub 2012 May 27.

Division of Endocrinology, Veterans Affairs Medical Center, University of California, San Francisco, CA 94121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-012-9610-9DOI Listing
July 2012

Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability.

Calcif Tissue Int 2012 Apr 1;90(4):330-42. Epub 2012 Mar 1.

Department of Orthodontics and Pediatric Dentistry, School of Dentistry, The University of Michigan, Ann Arbor, MI 48109-1078, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00223-012-9579-4
Publisher Site
http://dx.doi.org/10.1007/s00223-012-9579-4DOI Listing
April 2012

Transient muscle paralysis degrades bone via rapid osteoclastogenesis.

FASEB J 2012 Mar 28;26(3):1110-8. Epub 2011 Nov 28.

Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.11-196642DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289507PMC
March 2012

Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice.

Bone 2012 Mar 30;50(3):628-37. Epub 2011 Nov 30.

Division of Endocrinology, Veterans Affairs Medical Center, and Department of Medicine, University of California, San Francisco, San Francisco, CA 94121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2011.11.010DOI Listing
March 2012

Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.

J Biol Chem 2010 Sep 17;285(36):28164-73. Epub 2010 Jun 17.

Service of Bone Diseases, Department of Rehabilitation and Geriatrics, Geneva University Hospital and Faculty of Medicine, 1211 Geneva 14, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.101964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934681PMC
September 2010

RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis.

Bone 2010 Mar 30;46(3):752-8. Epub 2009 Oct 30.

Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, Guldhedsgatan 10A, S-41346 Göteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2009.10.028DOI Listing
March 2010

Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.

Arthritis Rheum 2009 Sep;60(9):2644-54

Department of Internal Medicine III and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Krankenhausstrasse 12, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.24767
Publisher Site
http://dx.doi.org/10.1002/art.24767DOI Listing
September 2009

Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.

Arthritis Rheum 2009 May;60(5):1427-37

Department of Medicine III, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.24445DOI Listing
May 2009

The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis.

Biomarkers 2008 Nov;13(7):692-712

Department of Metabolic Disorders, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13547500802651911 DOI Listing
November 2008

Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice.

Circulation 2008 Jan 2;117(3):411-20. Epub 2008 Jan 2.

Department of Molecular Cellular and Integrative Physiology, University of California, Los Angeles, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.107.707380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680735PMC
January 2008

RANKL inhibition: from mice to men (and women).

Adv Exp Med Biol 2007 ;602:143-50

Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-72009-8_18DOI Listing
December 2007

Dickkopf-1 is a master regulator of joint remodeling.

Nat Med 2007 Feb 21;13(2):156-63. Epub 2007 Jan 21.

Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nurnberg, Krankenhausstrasse 12, D-91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm1538DOI Listing
February 2007

RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.

J Bone Miner Res 2005 Oct 6;20(10):1756-65. Epub 2005 Jun 6.

Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1359/JBMR.050601DOI Listing
October 2005

Analysis of the kinetics of osteoclastogenesis in arthritic rats.

Arthritis Rheum 2005 Oct;52(10):3192-201

Amgen, Inc., Thousand Oaks, California 91320, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.21343DOI Listing
October 2005

Regulatory effects of osteoprotegerin on cellular and humoral immune responses.

Clin Immunol 2003 Dec;109(3):347-54

Amgen Inc, Thousand Oaks, CA 91320, USA.

View Article

Download full-text PDF

Source
December 2003

Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.

Clin Cancer Res 2003 Mar;9(3):961-8

University of California Los Angeles School of Medicine-Wadsworth Pulmonary Immunology Laboratory, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

View Article

Download full-text PDF

Source
March 2003

Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4.

Blood 2002 Apr;99(8):2869-79

Division of Pulmonary and Critical Care, Department of Medicine, UCLA School of Medicine, Los Angeles 90095-1690, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.8.2869DOI Listing
April 2002